Application of Tirofiban Hydrochloride Combined with Conventional Therapy in Patients with Acute Progressive Cerebral Infarction
Objective To investigate the effect of conventional treatment and tirofiban hydrochloride on patients with acute progressive cerebral infarction.Methods A total of 80 patients with acute progressive cerebral infarction admit-ted to Zaozhuang Central Hospital of Shandong Guoxin Yiyang Group from August 2022 to November 2023 were pur-posely selected as the study objects,and they were divided into conventional group and study group by different treat-ment modalities,with 40 cases in each group.The conventional group received conventional treatment intervention,and the study group received tirofiban hydrochloride combined with conventional treatment intervention.The index of coagulation function,incidence of adverse reactions and effective rate of treatment were compared between the two groups.Results After treatment,the total effective rate of the study group(97.50%)was higher than that of the conven-tional group(82.50%),and the difference was statistically significant(χ2=5.000,P<0.05).The coagulation function in-dex of the study group was better than that of the conventional group,and the differences were statistically significant(all P<0.05).The incidence of adverse reactions in the study group was slightly lower than that in the conventional group,with no statistical significance(P>0.05).Conclusion Conventional treatment combined with tirofiban hydro-chloride in patients with acute progressive cerebral infarction can significantly improve coagulation function,improve clinical efficacy,and have good safety.
万方数据
维普
